Publications

We have published hundreds of publications. You can see many of the Human Data Sciences team publications here, including the validation study for Livingstone^®

See a selection of our publications below.

Publications

We have published hundreds of publications. You can see many of the Human Data Sciences team publications here, including the validation study for Livingstone^®

See a selection of our publications below.

Recent Publications

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database

https://www.dovepress.com/clinical-impact-and-healthcare-resource-utilization-associated-with-ea-peer-reviewed-fulltext-article-COPD

Scientific independence and objectivity: many questions linger about treatment of type 2 diabetes, such as scientific study design, optimal glucose control and the safety of injecting exogenous insulin

https://www.tandfonline.com/doi/full/10.1080/00325481.2020.1784562

Retinal Thickness Fluctuations in Patients Receiving Fluocinolone Acetonide Implant for Diabetic Macular Edema

http://dx.doi.org/10.1080/03007995.2020.1754183

Healthcare utilization and associated costs following initiation of perampanel in patients with epilepsy

https://www.epilepsybehavior.com/article/S1525-5050(20)30316-4/fulltext

Cough Presentation in Primary Care and the Identification of Chronic Cough: a Need for Diagnostic Clarity?

http://dx.doi.org/10.1080/03007995.2019.1673716

Increased survival in patients with hepatic encephalopathy treated with rifaximin-alpha in combination with lactulose: an observational study from UK clinical practice

https://www.journal-of-hepatology.eu/article/S0168-8278(20)30626-7/pdf

Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom

http://dx.doi.org/10.1080/1744666X.2019.1641406

Evaluation of the epidemiology of peanut allergy in the United Kingdom

http://dx.doi.org/10.1080/1744666X.2020.1693264

Evaluation of the financial cost of treating people living with human immunodeficiency virus in the United Kingdom versus matched HIV-negative controls in 2004, 2010 and 2017

https://www.hivandmore.de/kongresse/eacs2019/Kearns-PE34_5-EVALUATION-OF-THE-FINANCIAL-COST-OF-TREATING-PEOPLE-LIVING-WITH.pdf

Primary and Secondary Healthcare Resource Use and Associated Costs in People with Hepatic Encephalopathy in England

https://www.valueinhealthjournal.com/article/S1098-3015(19)33389-3/pdf

The Model of Mortality with Incident Cirrhosis (MoMIC) and the Model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)

http://dx.doi.org/10.1371/journal.pone.0223253

Major Adverse Cardiovascular Events in People with Chronic Kidney Disease in Relation to Disease Severity and Diabetes Status

http://dx.doi.org/10.1371/journal.pone.0221044

Recent Publications

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database

https://www.dovepress.com/clinical-impact-and-healthcare-resource-utilization-associated-with-ea-peer-reviewed-fulltext-article-COPD

Scientific independence and objectivity: many questions linger about treatment of type 2 diabetes, such as scientific study design, optimal glucose control and the safety of injecting exogenous insulin

https://www.tandfonline.com/doi/full/10.1080/00325481.2020.1784562

Retinal Thickness Fluctuations in Patients Receiving Fluocinolone Acetonide Implant for Diabetic Macular Edema

http://dx.doi.org/10.1080/03007995.2020.1754183

Healthcare utilization and associated costs following initiation of perampanel in patients with epilepsy

https://www.epilepsybehavior.com/article/S1525-5050(20)30316-4/fulltext

Cough Presentation in Primary Care and the Identification of Chronic Cough: a Need for Diagnostic Clarity?

http://dx.doi.org/10.1080/03007995.2019.1673716

Increased survival in patients with hepatic encephalopathy treated with rifaximin-alpha in combination with lactulose: an observational study from UK clinical practice

https://www.journal-of-hepatology.eu/article/S0168-8278(20)30626-7/pdf

Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom

http://dx.doi.org/10.1080/1744666X.2019.1641406

Evaluation of the epidemiology of peanut allergy in the United Kingdom

http://dx.doi.org/10.1080/1744666X.2020.1693264

Evaluation of the financial cost of treating people living with human immunodeficiency virus in the United Kingdom versus matched HIV-negative controls in 2004, 2010 and 2017

https://www.hivandmore.de/kongresse/eacs2019/Kearns-PE34_5-EVALUATION-OF-THE-FINANCIAL-COST-OF-TREATING-PEOPLE-LIVING-WITH.pdf

Primary and Secondary Healthcare Resource Use and Associated Costs in People with Hepatic Encephalopathy in England

https://www.valueinhealthjournal.com/article/S1098-3015(19)33389-3/pdf

The Model of Mortality with Incident Cirrhosis (MoMIC) and the Model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)

http://dx.doi.org/10.1371/journal.pone.0223253

Major Adverse Cardiovascular Events in People with Chronic Kidney Disease in Relation to Disease Severity and Diabetes Status

http://dx.doi.org/10.1371/journal.pone.0221044

Publications

We have published hundreds of publications. You can see many of the Human Data Sciences team publications here, including the validation study for Livingstone®

See a selection of our publications below.

We have published hundreds of publications. You can see many of the Human Data Sciences team publications here, including the validation study for Livingstone®

See a selection of our publications below.

Recent Publications

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database

Scientific independence and objectivity: many questions linger about treatment of type 2 diabetes, such as scientific study design, optimal glucose control and the safety of injecting exogenous insulin

Retinal Thickness Fluctuations in Patients Receiving Fluocinolone Acetonide Implant for Diabetic Macular Edema

Healthcare utilization and associated costs following initiation of perampanel in patients with epilepsy

Cough Presentation in Primary Care and the Identification of Chronic Cough: a Need for Diagnostic Clarity?

Increased survival in patients with hepatic encephalopathy treated with rifaximin-alpha in combination with lactulose: an observational study from UK clinical practice

Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom

Evaluation of the epidemiology of peanut allergy in the United Kingdom

Evaluation of the financial cost of treating people living with human immunodeficiency virus in the United Kingdom versus matched HIV-negative controls in 2004, 2010 and 2017

Primary and Secondary Healthcare Resource Use and Associated Costs in People with Hepatic Encephalopathy in England

The Model of Mortality with Incident Cirrhosis (MoMIC) and the Model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)

Major Adverse Cardiovascular Events in People with Chronic Kidney Disease in Relation to Disease Severity and Diabetes Status

Recent Publications

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database

Scientific independence and objectivity: many questions linger about treatment of type 2 diabetes, such as scientific study design, optimal glucose control and the safety of injecting exogenous insulin

Retinal Thickness Fluctuations in Patients Receiving Fluocinolone Acetonide Implant for Diabetic Macular Edema

Healthcare utilization and associated costs following initiation of perampanel in patients with epilepsy

Cough Presentation in Primary Care and the Identification of Chronic Cough: a Need for Diagnostic Clarity?

Increased survival in patients with hepatic encephalopathy treated with rifaximin-alpha in combination with lactulose: an observational study from UK clinical practice

Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom

Evaluation of the epidemiology of peanut allergy in the United Kingdom

Evaluation of the financial cost of treating people living with human immunodeficiency virus in the United Kingdom versus matched HIV-negative controls in 2004, 2010 and 2017

Primary and Secondary Healthcare Resource Use and Associated Costs in People with Hepatic Encephalopathy in England

The Model of Mortality with Incident Cirrhosis (MoMIC) and the Model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)

Major Adverse Cardiovascular Events in People with Chronic Kidney Disease in Relation to Disease Severity and Diabetes Status

MEET OUR BRANDS

About HDS

HUMAN DATA SCIENCE

Logo

Colours

LIVINGSTONEIQ

Logo

Colours

PREVALENCEUK

Logo

Colours

TYPOGRAPHY

VOICE AND TONE

ICONS

We have published hundreds of publications. You can see many of the Human Data Sciences team publications here, including the validation study for Livingstone^®

We have published hundreds of publications. You can see many of the Human Data Sciences team publications here, including the validation study for Livingstone^®